Twitter | Search | |
OncoAlert
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are 🚨
28,050
Tweets
136
Following
10,216
Followers
Tweets
OncoAlert 56m
LIVE from Our 🚨colleague 👩‍⚕️of Discusses Gastric Destiny 01 Which reignited the concept of targeting🎯HER2 Beyond trastuzumab progression in ☑️Overall Response rate5⃣1⃣% Median OS over1⃣yr
Reply Retweet Like
OncoAlert retweeted
ESMO - Eur. Oncology 3h
ESMO Patient Guide on ' during ': just out the new adaptations to gastro-esophageal cancer management 👉
Reply Retweet Like
OncoAlert retweeted
ASCO 3h
We believe every pt w cancer should have access to quality care. That's why our affiliate, the Assoc. for Clinical Oncology advocates for increased federal funding for research, and greater access to health care &
Reply Retweet Like
OncoAlert retweeted
Gil Morgan 3h
Replying to @weoncologists
Reply Retweet Like
OncoAlert retweeted
Nature Research 21h
A new paper in looks at the factors affecting the severity of in patients with cancer. The authors provide some background to the research in a blog post on our Cancer Community.
Reply Retweet Like
OncoAlert 1h
Dear Friends Worldwide🌐 Our Great 🚨Colleague 👨‍⚕️has some wise words for us about the power of during this pandemic & the power of our VOICES. Give him a listen, as always he is RIGHT ON TARGET🎯 Best,
Reply Retweet Like
OncoAlert retweeted
ASTRO 1h
The 2020 ASTRO Radiation Oncology Coding Resource eBook has been updated to reflect recent changes to radiation oncology coding. Check out the summer update here:
Reply Retweet Like
OncoAlert retweeted
Raul Cordoba, MD, PhD 2h
Pilot prospective study of and Functionality in routine clinical assessment in allogeneic hematopoietic cell transplantation . Excellent work done by ⁦
Reply Retweet Like
OncoAlert retweeted
Yüksel Ürün 3h
"The creation of the ESMO Foundation is an essential project for me and is needed for ESMO too." 👏👏👏
Reply Retweet Like
OncoAlert retweeted
Pashtoon Kasi MD, MS 2h
Reply Retweet Like
OncoAlert retweeted
Sharlene Gill 9h
Replying to @GillSharlene
What do you currently offer for T4N1 colon cancer?
Reply Retweet Like
OncoAlert retweeted
Gil Morgan 3h
Our Amazing 🚨Colleague& President on creating ESMO foundation, developing a fair pricing& reimbursement model for medicines, comprehensive plan& policies to support Survivors Immensely proud of ESMO & my president! Gil
Reply Retweet Like
OncoAlert retweeted
A.n.n. 5h
Dr Tabernero reporting re I/O for V600 patients more re NCT04294160
Reply Retweet Like
OncoAlert retweeted
Symplur Hashtags 5h
Reply Retweet Like
OncoAlert retweeted
Pashtoon Kasi MD, MS 4h
Replying to @manjuggm @agrothey
in real world it’s not long before the mets appear or are already there➡️need a better imaging modality e.g. PET/CT or as in the 👆🏾case a liver MRI. Perfectly ripe opportunity for . 🩸🧬
Reply Retweet Like
OncoAlert retweeted
Dr. Iván R. González 3h
Tengo el placer de compartirles que gracias a nuestro interés por presentarles la información más actual en y el seguimiento de ustedes, ahora soy parte de los
Reply Retweet Like
OncoAlert retweeted
Gil Morgan 3h
Our Amazing 🚨Colleague& President on creating ESMO foundation, developing a fair pricing& reimbursement model for medicines, comprehensive plan& policies to support Survivors Immensely proud of ESMO & my president! Gil
Reply Retweet Like
OncoAlert 3h
Friends at Thanks for a great DAY3⃣& Special thanks to our hard working friends at & ! Our gratitude to all of our colleagues for their support & for making 🚨Oncologists 5⃣0⃣% of the top influences during the meeting Best
Reply Retweet Like
OncoAlert retweeted
Christian Rolfo 3h
Happy to be part of the team presenting the impressive data of Entrectinib in NTRK fusion positive GI cancer patients at
Reply Retweet Like
OncoAlert retweeted
Luca Dezzani 3h
Reply Retweet Like